Skip to main content
Premium Trial:

Request an Annual Quote

Philip Vorwald, Stephen Costalas, and Terence McGowan

Premium

Guava Technologies has appointed Philip Vorwald as the company’s new vice president of worldwide sales.

Vorwald joins Guava most recently from Delphi Medical Systems, where he served as managing director. Prior to this, he held several senior-level positions at Becton Dickinson Biosciences, including vice president of business operations for Europe/Middle East and Asia/Pacific/Latin America; and in strategic planning in the US, Guava said.

Vorwald holds an MS from the Medical College of Virginia and a BS from the Catholic University in Washington, DC.


Stephen Costalas has been named executive vice president, general counsel, and secretary at Pharmacopeia Drug Discovery, the Princeton, NJ-based company said last week.

Costalas joins PDD from the corporate and securities group of Dechert LLP, where he served as lead outside counsel to Pharmacopeia. He holds a JD from the University of Pennsylvania Law School, and an AB from Dartmouth College.


Terence McGowan has been appointed director of institutional advancement at the Boston Biomedical Research Institute, based in Watertown, Mass.

McGowan joins BBRI from Dana-Farber Cancer Institute, where he was associate director of corporate and foundation relations. He has also held positions at Specialized Health Management, SeniorLink, Brigham & Women’s Hospital, and Charles River Hospital.

 

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.